Drawing for R-TECH UENO

USPTO serial 79165140

R-TECH UENO

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
CARLSON, KRISTIN
Law office
TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with R-TECH UENO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical agents for ophthalmic use; pharmaceutical agents for treatment of otic and nasal disorders; pharmaceutical agents for the treatment of allergic symptoms; pharmaceutical agents for treatment of digestive organ disorders; pharmaceutical agents for the treatment of disorders of central nervous system; pharmaceutical agents for the treatment of cardiovascular diseases; hormones for medical and pharmaceutical purposes; pharmaceutical agents for treatment of urogenital and anal organ disorders; pharmaceutical preparations for skin care; pharmaceutical agents for treatment of dental and oral disorders; vitamin preparations; pharmaceutical agents for the treatment of blood or body fluid disorders; pharmaceutical agents for use in kidney dialysis treatments; pharmaceutical agents for the treatment of liver disorders; antidotes; pharmaceutical preparations for the treatment of alcohol, cigarette, and drug abuse; pharmaceutical preparations for the treatment of gout; enzyme preparations for medical use; pharmaceutical preparations for the treatment of diabetes; chondroitin preparations; adenosine preparations; lactagogues; pharmaceutical preparations for activating cellular functions; pharmaceutical preparations for the treatment of tumors; antibiotic preparations; chemotherapeutic agents; preparations for destroying parasites; pharmaceutical agents for use in the dispersal of medications within the body; diagnostic preparations for medical purposes; in vitro diagnostic preparations for medical purposes; alkaloidal narcotics for medical purposes; non- alkaloidal narcotics for medical purposes; chemical reagents for medical purposesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2017DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Oct 27, 2017DETHDEATH OF INTERNATIONAL REGISTRATION—
May 26, 2017INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Apr 21, 2017FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 8, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 8, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 8, 2016MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 8, 2016ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 12, 2016CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Feb 12, 2016CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Aug 15, 2015RFNTREFUSAL PROCESSED BY IB—
Jul 28, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 28, 2015RFRRREFUSAL PROCESSED BY MPU—
Jul 28, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 27, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 21, 2015DOCKASSIGNED TO EXAMINER—
May 22, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
May 18, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 15, 2015LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
May 14, 2015SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance